Gastrointestinal Drugs Market Invests In Oral Capsules For Making Effective Drugs

The Business Research Company’s Gastrointestinal Drugs Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, January 28, 2022 /EINPresswire.com/ -- Major companies in the gastrointestinal drug industry are investing in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs which can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are usually injected and only a fraction of the administered dose reaches the disease sites in the gastrointestinal tract. Thus, major companies such as Eli Lilly have been increasingly investing in making oral capsules for macromolecular drugs. The company invested $5 million to enter into a collaboration with Entrega to study the oral delivery of complex molecules, such as peptides to combat gastrointestinal diseases.

North America was the largest region in the global gastrointestinal drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the gastrointestinal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Read More On The Global Gastrointestinal Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

The global gastrointestinal drugs market size is expected to grow from $71.85 billion in 2021 to $75.63 billion in 2022 at a compound annual growth rate (CAGR) of 5.3%. The change in the market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The gastrointestinal drugs market value is expected to reach $105.51 billion in 2026 at a CAGR of 8.7%.

Major players covered in the global gastrointestinal drugs industry are Takeda Pharmaceuticals, Bayer AG, Abbott Laboratories, Otsuka Holdings Co ltd, Johnson & Johnson, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Sanofi S.A, Procter & Gamble and Daiichi Sankyo Company.

TBRC’s global gastrointestinal drugs market analysis report is segmented by type into antacids, antiulcerants, vitamin and minerals, antiobesity, antiemetics and antinauseants, antidiarrheals, by distribution channel into hospital pharmacies, retail pharmacies/ drug stores, others, by route of administration into oral, parenteral, others, by drug classification into branded drugs, generic drugs, by mode of purchase into prescription-based drugs, over-the-counter drugs.

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a gastrointestinal drugs market overview, forecast gastrointestinal drugs market size and growth for the whole market, gastrointestinal drugs market segments, geographies, gastrointestinal drugs market trends, gastrointestinal drugs market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Gastrointestinal Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2136&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2021 - By Product (Endoscopic Thermal Devices), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End User (Hospitals Or Clinics, Ambulatory Surgical Centers), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Clinical Nutrition Global Market Report 2021 - By Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), By Route Of Administration (Oral, Enteral, Parenteral), By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders), By End User (Pediatric, Adults, Geriatric), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/clinical-nutrition-global-market-report-2020-30-covid-19-growth-and-change

Antacids Global Market Report 2021 - By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Formulation Type (Tablet, Liquid, Powder), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

About The Business Research Company
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn